M. Port,¹ F. Hérodin,² M. Drouet,² M. Valente,² M. Majewski,¹ P. Ostheim,¹ A. Lamkowski,¹ S. Schüle,¹ F. Forcheron,² A. Tichy,³ I. Sirak,⁴ A. Malkova,⁵ B. V. Becker,⁶ D. A. Veit,⁶ S. Waldeck,⁶ C. Badie,⁷ G. O'Brien,⁷ H. Christiansen,⁸ J. Wichmann,⁸ G. Beutel,⁹ M. Davidkova,¹⁰ S. Doucha-Senf,¹ M. Abend<sup>1,*

1</sup>Bundeswehr Institute of Radiobiology, Munich Germany
²Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge, France
³Department of Radiobiology, Faculty of Military Health Sciences, University of Defence, Brno, Czech Republic and Biomedical Research Centre, University Hospital Hradec Králové, Hradec Králové, Czech Republic
⁴Department of Oncology and Radiotherapy, University Hospital, Hradec Králové, Hradec Králové, Czech Republic
⁵Department of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
⁶Bundeswehr Central Hospital, Department of Radiology and Neuroradiology, Koblenz, Germany
⁷Cancer Mechanisms and Biomarkers Group, Radiation Effects Department, Centre for Radiation, Chemical and Environmental Hazards, Public Health of England, Didcot, United Kingdom
⁸Departments of Radiation Oncology
⁹Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹⁰Department of Radiation Dosimetry, Nuclear Physics Institute of the Czech Academy of Sciences, Řež, Czech Republic

^* Address for correspondence: Bundeswehr Institute of Radiobiology affiliated to the University of Ulm, Neuherbergstr. 11, 80937 Munich, Germany; e-mail: michaelabend@bundeswehr.org.